Lu Lin
Fuzhou, 350001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
CypA inhibition attenuates diabetic hypoglycemia-induced cognitive impairment via the CD147/NF-κB/MMP-9 pathway.
Journal: Biochemical pharmacology
Published: September 23, 2025
Comparative study of National Institute of Health criteria and TNM staging system in predicting the prognosis of gastrointestinal stromal tumours: a retrospective study.
Journal: Frontiers in oncology
Published: May 04, 2025
Correlation analysis between hemoglobin and type 2 diabetic nephropathy: a two-center retrospective study.
Journal: Acta diabetologica
Published: December 16, 2024
Effect of PAI-1 inhibitor on pancreatic islet function and hepatic insulin resistance in db/db mice.
Effect of PAI-1 inhibitor on pancreatic islet function and hepatic insulin resistance in db/db mice.
Journal: Biochemical pharmacology
Published: October 30, 2024
Lactate supplementation after hypoglycemia alleviates cognitive dysfunction induced by recurrent non-severe hypoglycemia in diabetic mice.
Journal: Experimental neurology
Published: July 20, 2024
Upregulation of Metrnl improves diabetic kidney disease by inhibiting the TGF-β1/Smads signaling pathway: A potential therapeutic target.
Journal: PloS one
Published: April 17, 2024
Mitophagy disorder mediates cardiac deterioration induced by severe hypoglycemia in diabetic mice.
Journal: Molecular and cellular endocrinology
Published: April 15, 2023
Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage.
Journal: Molecular neurobiology
Published: June 28, 2022
Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated With Pericyte and Blood-Brain Barrier Dysfunction.
Journal: Frontiers in aging neuroscience
Published: September 13, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026